RABUWEL-LS contains Rabeprazole Sodium 20 mg (EC) + Levosulpiride 75 mg (SR), combining effective acid suppression with gastroprokinetic support for selected acid-related and motility disorders. A differentiated PCD Pharma Gastro product.
GERD and functional digestive disorders associated with impaired gastric motility.
To address both acid production and motility.
Take before meals as prescribed. Inform the physician about neurological, hormonal or cardiac conditions and other medicines being taken.
Headache, nausea, diarrhea, abdominal discomfort, dizziness and fatigue may occur.
RABUWEL-LS: Rabeprazole reduces gastric acid secretion, while Levosulpiride improves gastrointestinal motility and supports gastric emptying.
